Murakami S - Search Results

1

Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004.

Ishii I, Yokoyama N, Yanagimachi M, Ashikawa N, Hata M, Murakami S, Asami Y, Morisaki N, Saito Y, Ohmori S, Kitada M. Ishii I, et al. Among authors: murakami s. J Pharmacol Exp Ther. 1998 Oct;287(1):115-21. J Pharmacol Exp Ther. 1998. PMID: 9765329

2

Effect of the ACAT inhibitor, HL-004, on cholesterol metabolism in macrophages.

Murakami S, Yamagishi I, Asami Y, Sato M, Tomisawa K. Murakami S, et al. Cell Mol Biol (Noisy-le-grand). 1996 Sep;42(6):865-72. Cell Mol Biol (Noisy-le-grand). 1996. PMID: 8891354

3

The hypolipidemic action of the ACAT inhibitor HL-004 in hamsters fed normal chow.

Murakami S, Ohta Y, Asami Y, Yamagishi I, Toda Y, Sato M, Tomisawa K. Murakami S, et al. Gen Pharmacol. 1996 Dec;27(8):1383-6. doi: 10.1016/s0306-3623(96)00070-5. Gen Pharmacol. 1996. PMID: 9304411

4

The ACAT inhibitor HL-004 inhibits cholesterol absorption and lowers serum cholesterol in rats.

Asami Y, Kondo Y, Murakami S, Araki H, Tsuchida K, Higuchi S. Asami Y, et al. Among authors: murakami s. Gen Pharmacol. 1998 Oct;31(4):593-6. doi: 10.1016/s0306-3623(98)00046-9. Gen Pharmacol. 1998. PMID: 9792221

5

Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats.

Murakami S, Yamagishi I, Asami Y, Ohta Y, Toda Y, Nara Y, Yamori Y. Murakami S, et al. Pharmacology. 1996 May;52(5):303-13. doi: 10.1159/000139395. Pharmacology. 1996. PMID: 8807674

6

HL-004, the ACAT inhibitor, prevents the progression of atherosclerosis in cholesterol-fed rabbits.

Asami Y, Yamagishi I, Murakami S, Araki H, Tsuchida K, Higuchi S. Asami Y, et al. Among authors: murakami s. Life Sci. 1998;62(12):1055-63. doi: 10.1016/s0024-3205(98)00028-9. Life Sci. 1998. PMID: 9519807

7

Effects of HL-004, a novel ACAT inhibitor, on cholesterol accumulation and removal in cultured smooth muscle cells from stroke-prone spontaneously hypertensive rats (SHRSP).

Murakami S, Araki H, Otomo S, Nara Y, Yamori Y. Murakami S, et al. Life Sci. 1995;56(7):509-20. doi: 10.1016/0024-3205(94)00480-g. Life Sci. 1995. PMID: 7869831

8

Hypolipidemic and antiatherosclerotic effects of a novel ACAT inhibitor, HL-004, in stroke-prone spontaneously hypertensive rats.

Murakami S, Nara Y, Yamori Y. Murakami S, et al. Exp Mol Pathol. 1995 Aug;63(1):23-32. doi: 10.1006/exmp.1995.1027. Exp Mol Pathol. 1995. PMID: 8759051

9

Up-regulation of low density lipoprotein receptor by a novel isobenzofranone derivative, MD-700.

Murakami S, Nitanai I, Uchida S, Kondo-Ohta Y, Asami Y, Kondo K, Sato M, Kawashima A, Hara H, Tomisawa K, Mei HB, Xiang CZ. Murakami S, et al. Atherosclerosis. 1999 Oct;146(2):281-90. doi: 10.1016/s0021-9150(99)00148-3. Atherosclerosis. 1999. PMID: 10532684

10

ACAT inhibitor HL-004 accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats (SHRSP): stimulation of bile acid production by HL-004.

Murakami S, Yamagishi I, Sato M, Tomisawa K, Nara Y, Yamori Y. Murakami S, et al. Atherosclerosis. 1997 Aug;133(1):97-104. doi: 10.1016/s0021-9150(97)00121-4. Atherosclerosis. 1997. PMID: 9258412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,019 results

Search Page

Filters